# Exploratory assessment of preconception phthalate exposure on pregnancy and offspring health outcomes in mice

**Authors:** Maryam Afghah, Ansley C Elkins, Paige C Powell, Mary E Mulligan, Mary C Boland, Alexandra P Suggs, Melissa A Walker, Grace E Brenner, Lindsay C Johnson, Zachary J Padgett, Kylie D Rock

PMC · DOI: 10.1210/jendso/bvag010 · Journal of the Endocrine Society · 2026-01-23

## TL;DR

This study explores how exposure to phthalates before conception affects pregnancy outcomes and offspring health in mice, revealing long-term changes in maternal and fetal development.

## Contribution

The study identifies preconception phthalate exposure as a critical window influencing maternal and offspring health through sex-specific molecular and developmental changes.

## Key findings

- Preconception phthalate exposure altered maternal estrus cycles and liver gene expression related to metabolism and detoxification.
- Exposure led to sex-specific placental and offspring liver gene expression changes, with female placentas showing more extensive reprogramming.
- Male offspring exhibited reduced adult body weight and increased inflammatory gene expression, indicating long-term developmental programming.

## Abstract

Understanding how endocrine-disrupting chemicals influence reproductive success requires attention to sensitive windows beyond gestation, including the understudied preconception period. In this exploratory pilot study, female CD-1 mice were exposed to a human-relevant phthalate mixture (200 µg/kg/day) for 30 days prior to mating. Although implantation and litter size were unaffected, exposed dams exhibited nonsignificant shifts in estrus cyclicity, spending more time in proestrus and less in metestrus. Maternal liver transcriptomics revealed persistent changes more than a month after exposure ceased, with differential expression of genes involved in mitochondrial metabolism, oxidative phosphorylation, and xenobiotic processing, suggesting long-term metabolic reprograming in the absence of overt toxicity. Maternal effects coincided with developmental alterations at mid-gestation. At E14.5, fetuses from exposed dams were heavier, and placentas displayed expansion of the junctional zone, a region critical for endocrine function. This early growth enhancement reversed later in life, as exposed male offspring exhibited reduced adult body weight, consistent with altered developmental programing. Transcriptomic profiling revealed pronounced sex-specific placental responses: female placentas exhibited extensive reprograming across immune, metabolic, and extracellular matrix pathways (518 differentially expressed genes [DEGs]), whereas male placentas showed minimal differential expression (9 DEGs), despite enrichment for RNA processing and mitochondrial pathways. Adult offspring livers also displayed sex-specific transcriptional signatures, with exposed females downregulating metabolic and immune-regulatory genes and exposed males upregulating inflammatory pathways. Collectively, these hypothesis-generating findings provide early evidence that preconception exposures can shape maternal physiology, placental development, and long-term offspring health, highlighting the preconception period as a critical yet understudied window of susceptibility.

## Linked entities

- **Chemicals:** phthalate (PubChem CID 181977)

## Full-text entities

- **Genes:** CYP7B1 (cytochrome P450 family 7 subfamily B member 1) [NCBI Gene 9420] {aka CBAS3, CP7B, SPG5A}, ADM2 (adrenomedullin 2) [NCBI Gene 79924] {aka AM2, dJ579N16.4}, RPS2 (ribosomal protein S2) [NCBI Gene 6187] {aka LLREP3, S2, uS5}, CYP4F3 (cytochrome P450 family 4 subfamily F member 3) [NCBI Gene 4051] {aka CPF3, CYP4F, CYPIVF3, LTB4H}, SLC45A4 (solute carrier family 45 member 4) [NCBI Gene 57210], CYP7A1 (cytochrome P450 family 7 subfamily A member 1) [NCBI Gene 1581] {aka CP7A, CYP7, CYPVII}, GPR166P (G protein-coupled receptor 166, pseudogene) [NCBI Gene 442206] {aka GPCR, PGR9}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, GSTM2 (glutathione S-transferase mu 2) [NCBI Gene 2946] {aka GST4, GSTM, GSTM2-2, GTHMUS}, TPH1 (tryptophan hydroxylase 1) [NCBI Gene 7166] {aka TPRH, TRPH}, FIRRE (firre intergenic repeating RNA element) [NCBI Gene 286467] {aka LINC01200}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, HSD17B6 (hydroxysteroid 17-beta dehydrogenase 6) [NCBI Gene 8630] {aka HSE, RODH, SDR9C6}, PCDH9 (protocadherin 9) [NCBI Gene 5101], NOCT (nocturnin) [NCBI Gene 25819] {aka CCR4L, CCRN4L, Ccr4c, NOC}, ARVCF (ARVCF delta catenin family member) [NCBI Gene 421], MTHFR (methylenetetrahydrofolate reductase) [NCBI Gene 4524], SERPINA6 (serpin family A member 6) [NCBI Gene 866] {aka CBG}, GSTM1 (glutathione S-transferase mu 1) [NCBI Gene 2944] {aka GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1}, LEPR (leptin receptor) [NCBI Gene 3953] {aka CD295, LEP-R, LEPRD, OB-R, OBR, huB219}, TCF21 (transcription factor 21) [NCBI Gene 6943] {aka POD1, bHLHa23}, GH1 (growth hormone 1) [NCBI Gene 2688] {aka GH, GH-N, GHB5, GHN, IGHD1A, IGHD1B}, COL4A6 (collagen type IV alpha 6 chain) [NCBI Gene 1288] {aka CXDELq22.3, DELXq22.3, DFNX6}, HERC1 (HECT and RLD domain containing E3 ubiquitin protein ligase family member 1) [NCBI Gene 8925] {aka MDFPMR, p532, p619}, ELF4 (E74 like ETS transcription factor 4) [NCBI Gene 2000] {aka AIFBL2, ELFR, MEF}
- **Diseases:** anovulation (MESH:D000858), hepatic dysfunction (MESH:D008107), inflammation (MESH:D007249), growth restriction (MESH:D005317), mitochondrial function (MESH:D028361), loss of consciousness (MESH:D014474), preterm birth (MESH:D047928), infertility (MESH:D007246), EDCs (MESH:D004700), toxicity (MESH:D064420), DOHaD. (OMIM:603663), overnutrition (MESH:D044343), weight gain (MESH:D015430), pregnancy loss (MESH:D000022), liver disruptions (MESH:D017093), fetal overgrowth (MESH:D005315), reproductive and metabolic dysfunction (MESH:D060737), metabolic disease (MESH:D008659), maternal toxicity (MESH:D000079262), hypoxia (MESH:D000860)
- **Chemicals:** Chicago Blue dye (-), paraffin (MESH:D010232), DEP (MESH:C007379), NaCl (MESH:D012965), bile acid (MESH:D001647), H&amp;E (MESH:D006371), DiBP (MESH:C025605), glycerophospholipid (MESH:D020404), phosphatidylinositol (MESH:D010716), Phthalate (MESH:C032279), xylene (MESH:D014992), catecholamines (MESH:D002395), corn oil (MESH:D003314), dUTP (MESH:C027078), estradiol (MESH:D004958), carboxylic acid (MESH:D002264), BzBP (MESH:C027561), carbon (MESH:D002244), Tocopherol (MESH:D024505), DBP (MESH:D003993), PVC (MESH:D011143), pentobarbital (MESH:D010424), fatty acid (MESH:D005227), ATP (MESH:D000255), glutathione (MESH:D005978), CO2 (MESH:D002245), poly-sulfone (MESH:C017662), steroid (MESH:D013256), lipid (MESH:D008055), sucrose (MESH:D013395), glycogen (MESH:D006003), isoflurane (MESH:D007530), bisphenol A (MESH:C006780), propofol (MESH:D015742), alcohol (MESH:D000438), DEHP (MESH:D004051), progesterone (MESH:D011374), glucose (MESH:D005947), serotonin (MESH:D012701), ethanol (MESH:D000431), poly-T (MESH:D011071), DiNP (MESH:C012125), toluidine blue (MESH:D014048), cholesterol (MESH:D002784), reactive oxygen species (MESH:D017382), folate (MESH:D005492)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12922444/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12922444/full.md

## References

151 references — full list in the complete paper: https://tomesphere.com/paper/PMC12922444/full.md

---
Source: https://tomesphere.com/paper/PMC12922444